{"id":32336,"date":"2026-07-08T03:28:00","date_gmt":"2026-07-08T01:28:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=730252301ffc890bc19b72c377fcea06"},"modified":"2026-07-08T03:28:00","modified_gmt":"2026-07-08T01:28:00","slug":"securities-fraud-investigation-into-unicycive-therapeutics-inc-uncy-announced-shareholders-who-lost-money-urged-to-contact-the-law-offices-of-frank-r-cruz","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=32336","title":{"rendered":"Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced \u2013 Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz<\/a> announces an investigation of Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d or the \u201cCompany\u201d) (NASDAQ: UNCY<\/a>) on behalf of investors concerning the Company\u2019s possible violations of federal securities laws.<\/p><\/a><\/a>

IF YOU ARE AN INVESTOR WHO LOST MONEY ON UNICYCIVE THERAPEUTICS, INC. (UNCY), CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.<\/b><\/p>

What Is The Investigation About?<\/b><\/p>

On June 30, 2026, Unicycive disclosed that the FDA had issued a second Complete Response Letter (\u201cCRL\u201d) regarding the Company\u2019s resubmitted New Drug Application for its kidney disease therapy, oxylanthanum, identifying the \u201csame third-party manufacturing deficiencies that were identified in the previous CRL issued in June 2025<\/b><\/i>.\u201d<\/p>

On this news, Unicycive\u2019s stock price fell $3.01, or 39.1%, to close at $4.69 per share on June 30, 2026, thereby injuring investors.<\/p>

Contact Us To Participate or Learn More:<\/b><\/p>

If you purchased Unicycive securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:<\/p>

The Law Offices of Frank R. Cruz,2121 Avenue of the Stars, Suite 800,Century City, California 90067Call us at: 310-914-5007Email us at: info@frankcruzlaw.com<\/a>Visit our website at: www.frankcruzlaw.com<\/a>.Follow us for updates on Twitter at twitter.com\/FRC_LAW<\/a>.<\/p>

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.<\/p>

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz310-914-5007fcruz@frankcruzlaw.com<\/a>www.frankcruzlaw.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Unicycive Therapeutics, Inc. (\u201cUnicycive\u201d or the \u201cCompany\u201d) (NASDAQ: UNCY) on behalf of investors concerning the Company\u2019s possible violations of federal secur…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32336","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32336"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32336\/revisions"}],"predecessor-version":[{"id":32337,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32336\/revisions\/32337"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}